Top

Published in:

01-03-2007 | Original Article

Genetic variation of FUT2 in a Ghanaian population: identification of four novel mutations and inference of balancing selection

Authors: Mikiko Soejima, Hao Pang, Yoshiro Koda

Published in: Annals of Hematology | Issue 3/2007

Abstract

The FUT2 is rich in polymorphisms that show population-specific patterns in its coding sequence. In this study, we found four novel substitutions in 121 Ghanaian samples. In addition, statistical tests considering population expansion scenarios suggested that balancing selection might be responsible for the genetic diversity of FUT2 in this population.

Boren T, Falk P, Roth KA, Larson G, Normark S (1993) Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262:1892–1895PubMedCrossRef

Chang JG, Yang TY, Liu TC, Lin TP, Hu CJ, Kao MC, Wang NM, Tsai FJ, Peng CT, Tsai CH (1999) Molecular analysis of secretor type α(1,2)-fucosyltransferase gene mutations in the Chinese and Thai populations. Transfusion 39:1013–1017PubMedCrossRef

Excoffier L (2002) Human demographic history: refining the recent African origin model. Curr Opin Genet Dev 12:675–682PubMedCrossRef

Fu YX, Li WH (1993) Statistical tests of neutrality of mutations. Genetics 133:693–709PubMed

Griffiths RC, Tavare S (1994) Sampling theory for neutral alleles in a varying environment. Philos Trans R Soc Lond B Biol Sci 344:403–410PubMedCrossRef

Griffiths RC, Tavare S (1994) Simulating probability distributions in the coalescent. Theor Popul Biol 46:131–159CrossRef

Horai S, Satta Y, Hayasaka K, Kondo R, Inoue T, Ishida T, Hayashi S, Takahata N (1992) Man’s place in Hominoidea revealed by mitochondrial DNA genealogy. J Mol Evol 35:32–43PubMedCrossRef

Hudson RR (2002) Generating samples under a Wright–Fisher neutral model of genetic variation. Bioinformatics 18:337–338PubMedCrossRef

Hurd EA, Domino SE (2004) Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis. Infect Immun 72:4279–4281PubMedCrossRef

10.

Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB (1995) Sequence and expression of a candidate for the human secretor blood group α(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270:4640–4649PubMedCrossRef

11.

Koda Y, Soejima M, Liu Y, Kimura H (1996) Molecular basis for secretor type α(1,2)-fucosyltransferase gene deficiency in a Japanese population: a fusion gene generated by unequal crossover responsible for the enzyme deficiency. Am J Hum Genet 59:343–350PubMed

12.

Koda Y, Soejima M, Johnson PH, Smart E, Kimura H (2000) An Alu-mediated large deletion of the FUT2 gene in individuals with the ABO–Bombay phenotype. Hum Gen 106:80–85CrossRef

13.

Koda Y, Tachida H, Soejima M, Takenaka O, Kimura H (2000) Ancient origin of the null allele se⁴²⁸ of the human ABO-secretor locus (FUT2). J Mol Evol 50:243–248PubMed

14.

Koda Y, Soejima M, Kimura H (2001) The polymorphisms of fucosyltransferases. Leg Med (Tokyo) 3:2–14

15.

Koda Y, Tachida H, Pang H, Liu Y, Soejima M, Ghaderi AA, Takenaka O, Kimura H (2001) Contrasting patterns of polymorphisms at the ABO-secretor gene (FUT2) and plasma α(1,3)fucosyltransferase gene (FUT6) in human populations. Genetics 158:747–756PubMed

16.

Koda Y, Ishida T, Tachida H, Wang B, Pang H, Soejima M, Soemantri A, Kimura H (2003) DNA sequence variation of the human ABO-secretor locus (FUT2) in New Guinean populations: possible early human migration from Africa. Hum Genet 113:534–541PubMedCrossRef

17.

Larsen RD, Ernst LK, Nair RP, Lowe JB (1990) Molecular cloning, sequence, and expression of a human GDP-l-fucose:β-d-galactoside 2-α-l-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA 87:6674–6678PubMedCrossRef

18.

Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R (2003) Human susceptibility and resistance to Norwalk virus infection. Nat Med 9:548–553PubMedCrossRef

19.

Liu Y, Koda Y, Soejima M, Pang H, Schlaphoff T, duToit ED, Kimura H (1998) Extensive polymorphism of the FUT2 gene in an African (Xhosa) population of South Africa. Hum Genet 103:204–210PubMedCrossRef

20.

Liu YH, Koda Y, Soejima M, Pang H, Wang BJ, Kim DS, Oh HB, Kimura H (1999) The fusion gene at the ABO-secretor locus (FUT2): absence in Chinese populations. J Hum Genet 44:181–184PubMedCrossRef

21.

Marth GT, Czabarka E, Murvai J, Sherry ST (2004) The allele frequency spectrum in genome-wide human variation data reveals signals of differential demographic history in three large world populations. Genetics 166:351–372PubMedCrossRef

22.

Nakajima T, Yazawa S, Miyazaki S, Furukawa K (1993) Immunochemical characterization of anti-H monoclonal antibodies obtained from a mouse immunized with human saliva. J Immunol Methods 159:261–267PubMedCrossRef

23.

Nei M, Tajima F (1981) DNA polymorphism detectable by restriction endonucleases. Genetics 97:145–163PubMed

24.

Pang H, Fujitani N, Soejima M, Koda Y, Islam MN, Islam AK, Kimura H (2000) Two distinct Alu-mediated deletions of the human ABO-secretor (FUT2) locus in Samoan and Bangladeshi populations. Human Mutat 16:274CrossRef

25.

Pang H, Koda Y, Soejima M, Fujitani N, Ogaki T, Saito A, Kawasaki T, Kimura H (2001) Polymorphism of the human ABO-Secretor locus (FUT2) in four populations in Asia: indication of distinct Asian subpopulations. Ann Hum Genet 65:429–437PubMedCrossRef

26.

Peng CT, Tsai CH, Lin TP, Perng LI, Kao MC, Yang TY, Wang NM, Liu TC, Lin SF, Chang JG (1999) Molecular characterization of secretor type α(1, 2)-fucosyltransferase gene deficiency in the Philippine population. Ann Hematol 78:463–467PubMedCrossRef

27.

Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R (2003) DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19:2496–2497PubMedCrossRef

28.

Soejima M, Koda Y (2005) Denaturing high-performance liquid chromatography-based genotyping and genetic variation of FUT2 in Sri Lanka. Transfusion 45:1934–1939PubMedCrossRef

29.

Soejima M, Tachida H, Tsuneoka M, Takenaka O, Kimura H, Koda Y (2005) Nucleotide sequence analyses of human complement 6 (C6) gene suggest balancing selection. Ann Hum Genet 69:239–252PubMedCrossRef

30.

Soejima M, Tachida H, Ishida T, Sano A, Koda Y (2006) Evidence for recent positive selection at the human AIM1 locus in a European population. Mol Biol Evol 23:179–188PubMedCrossRef

31.

Stiner MC, Munro ND, Surovell TA, Tchernov E, Bar-Yosef O (1999) Paleolithic population growth pulses evidenced by small animal exploitation. Science 283:190–194PubMedCrossRef

32.

Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585–595PubMed

33.

Teye K, Quaye IK, Koda Y, Soejima M, Pang H, Tsuneoka M, Amoah AG, Adjei A, Kimura H (2004) A novel I247T missense mutation in the haptoglobin 2 β-chain decreases the expression of the protein and is associated with ahaptoglobinemia. Hum Genet 114:499–502PubMedCrossRef

34.

Watterson GA (1975) On the number of segregating sites in genetical model without recombination. Theor Popul Biol 7:256–276PubMedCrossRef

35.

Wooding S, Kim UK, Bamshad MJ, Larsen J, Jorde LB, Drayna D (2004) Natural selection and molecular evolution in PTC, a bitter-taste receptor gene. Am J Hum Genet 74:637–646PubMedCrossRef

Title: Genetic variation of FUT2 in a Ghanaian population: identification of four novel mutations and inference of balancing selection
Authors: Mikiko Soejima
Hao Pang
Yoshiro Koda
Publication date: 01-03-2007
Publisher: Springer-Verlag
Published in: Annals of Hematology / Issue 3/2007
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-006-0203-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2007

Pure red cell aplasia in a patient of chronic granulocyte leukemia associated with imatinib

Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates

Whole blood laboratory model of thrombocytopenia for use in evaluation of hemostatic interventions

Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin

Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology

Thrombotic thrombocytopenic purpura as the initial presentation of Pneumocystis jiroveci pneumonia in an immunocompetent patient

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials